|
| Analyst
Scorecard | | Analyst: | Abrahams, Brian | EPS
Est. Accuracy: | 
| | Broker: | Oppenheimer & Co. | Recommendation
Performance: | 
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
Industry Coverage
| | |
Industry
|
EPS Est. Accuracy
|
Industry Excess Return
|
Industry Return
| | | |
Biotechnology
|
|
9.5%
| Not Avl.
| | | |
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
BMRN
|
Biomarin Pharmaceutical Inc
|
|
18
| | | | |
CHTP
|
Chelsea Therapeutics Internation
|
|
5
| | | | |
CYPB
|
Cypress Bioscience Inc
|
|
6
| | | | |
GENZ
|
Genzyme Corp
|
|
21
| | | | |
ITMN
|
Intermune Inc.
|
|
12
| | | | |
NBIX
|
Neurocrine Biosciences Inc
|
|
6
| | | | |
RDEA
|
Ardea Biosciences Inc
| 
|
7
| | | |
| Other Stocks Covered
| |
Anadys Pharmaceuticals Inc (ANDS), Celgene Corporation (CELG), Idenix Pharmaceuticals Inc (IDIX), Novavax Inc (NVAX), Protalix Biotherapeutics Inc (PLX), Rigel Pharmaceuticals (RIGL), Zymogenetics Inc. (ZGEN)
|
| | |
|
|
|